Better Diabetes Control, Quality - Educate to Achieve Compliance.
NCT ID: NCT01728714
Last Updated: 2023-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
227 participants
OBSERVATIONAL
2014-05-19
2018-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Health Education Program for Type 2 Diabetes Patients
NCT06066021
Community Health Workers and Diabetes Education
NCT02811874
Structured Diabetes Self-Management Education in Primary Care and Metabolic Control
NCT01473329
An Intervention Program to Control Diabetes
NCT00543621
Differing Completion Rates of DIABETES Education on Patient Reported Outcomes
NCT06419907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults over 18 years old
Adults over 18 years old, with type 2 diabetes, HbA1c \<= 8,5%, treated with oral antidiabetics at least for 6 months submitted to an educational programme during 1 year
No interventions assigned to this group
Adults with HbA1c <= 8,5%
Adults over 18 years old, with type 2 diabetes, HbA1c \<= 8,5%, treated with oral antidiabetics at least for 6 months followed according to normal clinical practice during 1 year
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HbA1c \<= 8,5%
* Treated with oral antidiabetics for at least 6 months
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cláudia Antão
Role: PRINCIPAL_INVESTIGATOR
Research Site 01
Pedro Carriço
Role: PRINCIPAL_INVESTIGATOR
Research site 02
Carla Gouveia
Role: PRINCIPAL_INVESTIGATOR
Research site 03
Jorge Vinagre
Role: PRINCIPAL_INVESTIGATOR
Research site 04
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Almada, , Portugal
Research Site
Espinho, , Portugal
Research Site
Loures, , Portugal
Research Site
Oeiras, , Portugal
Research Site
Santo Antonio Dos Cavaleiros, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CV/No drug/NIS-CPO-XXX-2012/1
Identifier Type: OTHER
Identifier Source: secondary_id
NIS-CPO-XXX-2012/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.